Stiftingtalstraße 14 | 8010 Graz, Austria

We’re thrilled to share recent press coverage highlighting Cycuria Therapeutics‘ innovative approach in oncology and our choice to establish roots in Graz’s Medical Science City, a growing hub for biotech and healthcare innovation. Read the full conversation of our scientific founder, Prof. Dr. Philipp Jost, with the press outlet MEDitio here .

Share:

More Posts

At Cycuria, we are dedicated to developing novel cytokine-based therapies to dramatically improve outcomes for patients living with cancer, offering hope where traditional treatments have fallen short.